New paradigms in cell death in human diabetic nephropathy
New paradigms in cell death in human diabetic nephropathy
7 de septiembre de 2010
Unbiased gene expression profiling identified novel cell death molecules in human diabetic nephropathy. The expression of TNFrelated apoptosis-inducing ligand (TRAIL), its decoy receptor osteoprotegerin, and receptors Fas (a Fas ligand receptor) and CD74 (a migration inhibitory factor (MIF) receptor) were induced in human diabetic nephropathy. Cell culture studies supported the functional relevance of this observation and the relationship to a high glucose environment. To define novel proapoptotic proteins upregulated in diabetic nephropathy, functional genomic screens for novel apoptosis mediators were integrated with genome-wide expression profiling and identified candidates for further functional analysis, including brain acid-soluble protein 1 (BASP1). Several lines of evidence point toward induction of endoplasmic reticulum stress response in human diabetic nephropathy. Functional studies defining an unequivocal contribution of endoplasmic reticulum stress to cell death in this setting are still needed. Further comparative studies will be required to define whether there is a specific aspect of apoptosis in progressive human diabetic nephropathy or whether the mechanisms are shared among all patients with chronic kidney disease. The next challenge will be to define the consequence of therapeutic interference of the apoptosis pathways in diabetic nephropathy and chronic kidney disease.
Ficheros disponibles
Actualidad
Actualidad
Actualidad Quirónsalud: al día contigo
- 19 de junio de 2025
El Hospital Quirónsalud Murcia participa en el Congreso Regional de Calidad Asistencial
La doctora Paula Rodríguez, responsable Asistencial Territorial de la Unidad de Transformación del Modelo Asistencial de Quirónsalud en Levante, ha participado en una nueva e...Hospital Quirónsalud Murciaes/red-centros/hospital-quironsalud-murcia - 19 de junio de 2025
El conocimiento del factor hereditario, clave en el diagnóstico precoz y el tratamiento personalizado...
El hospital mostoleño celebra la jornada “Cáncer de vejiga y próstata metastásico: Tendiendo puentes”Hospital Universitario Rey Juan Carloses/red-centros/hospital-universitario-rey-juan-carlos - 19 de junio de 2025
Avances en el tratamiento del dolor crónico: Policlínica Gipuzkoa organiza una charla abierta sobre las...
El Aula de Salud “Vivir sin dolor. Innovación y últimos avances en el tratamiento del dolor”, se celebrará hoy, jueves 19 de junio, a las 19:00 horas, en el Auditorio del Rea...Hospital de Día Quirónsalud Donostiaes/red-centros/hospital-dia-quironsalud-donostiaPoliclínica Gipuzkoaes/red-centros/policlinica-gipuzkoaAnestesiología y Reanimaciónes/especialidades/anestesiologia-reanimacion